Sub-Total: $0.00
News
News
H1N1 and Mass Screening for Fever
On June 11, 2009, Dr. Margaret Chan, Director General of the World Health Organization, raised the level of influenza pandemic alert from phase 5 to phase 6, and declared: “The world is now at the start of the 2009 influenza pandemic.” The US Centers for Disease Control and Prevention (CDC) reported on November 12, 2009, […] Read More →
Exergen TemporalScanner Effective in Detecting Fevers in Children Aged 1-4 Years, Study Finds
WATERTOWN, Mass., Nov 16, 2009 /PRNewswire via COMTEX/ — “Temporal artery thermometry is an effective screening tool in identifying fever in children one to four years of age,” according to a recent study published in the journal Clinical Pediatrics. The study investigated the sensitivity and specificity of scanning the forehead area to detect temporal artery […] Read More →
Green Cash Flow
How does manufacturer-financed new technologyincreaseimmediatecashflowforcash-short hospitals? Francesco Pompei. First, a new technology must cost less and deliver improved patient care. In the current climate, unless both criteria are met, a new technology may not be a good deal for the hospital, or for the patient. Second, out-of-pocket cost of acquisition of the new technology must […] Read More →
Nurses Choose Exergen TemporalScanner™ Thermometer as 'Most Valuable Product'…
Nurses Choose Exergen TemporalScanner™ Thermometer as ‘Most Valuable Product’ in Annual Industry Survey WATERTOWN, Mass., July 30 /PRNewswire/ ‐‐ Exergen Corporation’s patented TemporalScanner™ Thermometer was selected by nurses as the 2009 Most Valuable Product in the annual survey by Therapy Times, the only all‐inclusive community Web site for therapeutic professionals in the healthcare industry. Hundreds […] Read More →
Non-Invasive Temporal Artery Thermometry: Physics, Physiology, and Clinical Accuracy
Francesco Pompei*a,b and Marybeth Pompeia a Exergen Corporation, 51 Water Street, Watertown, MA, USA 02472; b Dept. of Physics, Harvard University, Cambridge, MA, USA 02139 Download Full Article in PDF for here. ABSTRACT Temporal artery (TA) thermometry was developed in answer to requests by pediatricians for a replacement for: 1) ear thermometry due to inaccuracy; […] Read More →
Members to Benefit from New Agreement Between Amerinet Choice and Exergen Corporation
Amerinet Choice, the private-label and sourcing program of Amerinet Inc., announces a new agreement with Exergen Corporation for temporal artery thermometry products. Effective April 1, 2009, through March 31, 2012, the contract offers Amerinet members significant savings on Exergen products. Exergen creates non-invasive temperature measurement devices providing lower cost, higher accuracy, less invasiveness and greater […] Read More →
Renewing the Oldest Vital Sign
Fever was known as a vital sign to ancient Egyptians at least 5000 years ago, using the hand as measuring instrument. Galileo invented the first thermometer 500 years ago. Carl Wunderlich, ‘Father of Clinical Thermometry,’proposed 98.6°F (37°C) as the mean normal temperature 140 years ago. Until very recently we have been taking patients’ temperatures more […] Read More →
Exergen Sues Kidz-Med and Others Over Thermometer Patents
Exergen Corporation, headquartered in Watertown, MA, has filed a lawsuit in the U.S. District Court of Massachusetts against Kidz-Med Inc. of New Paltz, NY, American Scientific Resources, Inc. of Weston, FL, and Techni-Med S.R.L. of Italy, the suppliers of the Thermofocus thermometer, alleging that the defendants have infringed five US patents owned by Exergen. The […] Read More →
- « Previous
- 1
- …
- 66
- 67
- 68